Synthesis of Novel Caspase Inhibitors for Characterization of the Active Caspase Proteome in Vitro and in Vivo

por Henzing, Alexander J., Dodson, Helen, Reid, Joel M., Kaufmann, Scott H., Baxter, Robert L., Earnshaw, William C.
Publicado 2006

Quantification of the Impact of Enzyme-Inducing Antiepileptic Drugs on Irinotecan Pharmacokinetics and SN-38 Exposure

por Berg, Alexander K., Buckner, Jan C., Galanis, Evanthia, Jaeckle, Kurt A., Ames, Matthew M., Reid, Joel M.
Publicado en J Clin Pharmacol (2015)

Tuning Pharmacokinetics and Biodistribution of a Targeted Drug Delivery System Through Incorporation of a Passive Targeting Component

por Kudgus, Rachel A., Walden, Chad A., McGovern, Renee M., Reid, Joel M., Robertson, J. David, Mukherjee, Priyabrata
Publicado 2014

Comparative Metabolism of Batracylin (NSC 320846) and N-acetylbatracylin (NSC 611001) Using Human, Dog, and Rat Preparations In Vitro

por Covey, Joseph M, Reid, Joel M, Buhrow, Sarah A, Kuffel, Mary, Walden, Chad, Behrsing, Holger, Ames, Matthew M
Publicado en J Drug Metab Toxicol (2016)

Two Different Methods of Quantification of Oxidized Nicotinamide Adenine Dinucleotide (NAD(+)) and Reduced Nicotinamide Adenine Dinucleotide (NADH) Intracellular Levels: Enzymatic...

por Kanamori, Karina S., de Oliveira, Guilherme C., Auxiliadora-Martins, Maria, Schoon, Renee A., Reid, Joel M., Chini, Eduardo N.
Publicado en Bio Protoc (2018)

Mouse pharmacokinetics and metabolism of the curcumin analog, 4-Piperidione,3,5-bis[(2-fluorophenyl)methylene]-acetate(3E,5E) (EF-24; NSC 716993)

por Reid, Joel M., Buhrow, Sarah A., Gilbert, Judith A., Jia, Lee, Shoji, Mamoru, Snyder, James P., Ames, Matthew M.
Publicado en Cancer Chemother Pharmacol (2014)

Controlled Delivery of Vancomycin via Charged Hydrogels

por Gustafson, Carl T., Boakye-Agyeman, Felix, Brinkman, Cassandra L., Reid, Joel M., Patel, Robin, Bajzer, Zeljko, Dadsetan, Mahrokh, Yaszemski, Michael J.
Publicado en PLoS One (2016)

Serum Triamcinolone Levels following Cervical Interlaminar Epidural Injection

por Lamer, Tim J., Dickson, Rozalin R., Gazelka, Halena M., Nicholson, Wayne T., Reid, Joel M., Moeschler, Susan M., Hooten, W. Michael
Publicado en Pain Res Manag (2018)

Reductive Amination of α-Ketoglutarate in Metabolite Extracts Results in Glutamate Overestimation

por Wiese, Elizabeth K., Hitosugi, Sadae, Buhrow, Sarah A., Loa, Sharon T., Sreedhar, Annapoorna, Reid, Joel M., Gonsalves, Wilson I., Hitosugi, Taro
Publicado en J Chromatogr A (2020)

Inhibiting the Growth of Pancreatic Adenocarcinoma In Vitro and In Vivo through Targeted Treatment with Designer Gold Nanotherapeutics

por Kudgus, Rachel A., Szabolcs, Annamaria, Khan, Jameel Ahmad, Walden, Chad A., Reid, Joel M., Robertson, J. David, Bhattacharya, Resham, Mukherjee, Priyabrata
Publicado 2013

A Phase 1 and Pharmacokinetic Clinical Trial of Paclitaxel for the Treatment of Refractory Leukemia in Children: A Children’s Oncology Group Study

por Horton, Terzah M., Ames, Matthew M., Reid, Joel M., Krailo, Mark D., Pendergrass, Thomas, Mosher, Revonda, Reaman, Gregory H., Seibel, Nita L.
Publicado en Pediatr Blood Cancer (2008)

CYP2C9 and CYP2C19: Deep Mutational Scanning and Functional Characterization of Genomic Missense Variants

por Zhang, Lingxin, Sarangi, Vivekananda, Moon, Irene, Yu, Jia, Liu, Duan, Devarajan, Sandhya, Reid, Joel M., Kalari, Krishna R., Wang, Liewei, Weinshilboum, Richard
Publicado en Clin Transl Sci (2020)

Comparative Uterotrophic Effects of Endoxifen and Tamoxifen in Ovariectomized Sprague Dawley Rats

por Schweikart, Karen M., Eldridge, Sandy R., Safgren, Stephanie L., Parman, Toufan, Reid, Joel M., Ames, Matthew M., Goetz, Matthew P., Davis, Myrtle A.
Publicado 2014

Neuroprotection mediated by inhibition of calpain during acute viral encephalitis

por Howe, Charles L., LaFrance-Corey, Reghann G., Mirchia, Kanish, Sauer, Brian M., McGovern, Renee M., Reid, Joel M., Buenz, Eric J.
Publicado en Sci Rep (2016)

Toxicology and pharmacokinetics of 1-methyl-[D]-tryptophan: absence of toxicity due to saturating absorption

por Jia, Lee, Schweikart, Karen, Tomaszewski, Joseph, Page, John G., Noker, Patricia E., Buhrow, Sarah A., Reid, Joel M., Ames, Matthew M., Munn, David H.
Publicado 2007

A Phase 1 Study of the c-Met Inhibitor, Tivantinib (ARQ197) in Children with Relapsed or Refractory Solid Tumors: A Children’s Oncology Group Study Phase 1 and Pilot Consortium Tri...

por Geller, James I., Perentesis, John P., Liu, Xiaowei, Minard, Charles G., Kudgus, Rachel A., Reid, Joel M., Fox, Elizabeth, Blaney, Susan M., Weigel, Brenda J.
Publicado en Pediatr Blood Cancer (2017)

A Study of Axitinib (INLYTA(™)), a VEGF Receptor Tyrosine Kinase Inhibitor, in Children and Adolescents with Recurrent or Refractory Solid Tumors: A Children’s Oncology Group Phase...

por Geller, James I., Fox, Elizabeth, Turpin, Brian, Goldstein, Stuart, Liu, Xiaowei, Minard, Charles G., Kudgus, Rachel A., Reid, Joel M., Berg, Stacey, Weigel, Brenda J.
Publicado en Cancer (2018)

Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumors

por Bryce, Alan H., Rao, Ravi, Sarkaria, Jann, Reid, Joel M., Qi, Yingwei, Qin, Rui, James, C. David, Jenkins, Robert B., Boni, Joseph, Erlichman, Charles, Haluska, Paul
Publicado 2011

Population Pharmacokinetic Model for Cancer Chemoprevention With Sulindac in Healthy Subjects

por Berg, Alexander K., Mandrekar, Sumithra J., Ziegler, Katie L. Allen, Carlson, Elsa C., Szabo, Eva, Ames, Mathew M., Boring, Daniel, Limburg, Paul J., Reid, Joel M.
Publicado 2013

Phase 2 Trial of Cixutumumab in Children, Adolescents and Young Adults with Refractory Solid Tumors: A Report from the Children's Oncology Group

por Weigel, Brenda, Malempati, Suman, Reid, Joel M., Voss, Stephan D., Cho, Steven Y., Chen, Helen X., Krailo, Mark, Villaluna, Doojduen, Adamson, Peter C., Blaney, Susan M.
Publicado en Pediatr Blood Cancer (2013)